2021
DOI: 10.1016/s2352-3018(21)00005-9
|View full text |Cite
|
Sign up to set email alerts
|

HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

10
38
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(48 citation statements)
references
References 17 publications
10
38
0
Order By: Relevance
“…[8][9][10] However, without PrEP nonusers as controls, whether the observed low HIV incidence was due to participants' low HIV risk or PrEP effectiveness was unclear. Recently, a study from Africa 11 compared HIV incidence among D-PrEP and ED-PrEP users with that of historical controls. To our knowledge, no study has included a parallel group of PrEP nonusers.…”
Section: Introductionmentioning
confidence: 99%
“…[8][9][10] However, without PrEP nonusers as controls, whether the observed low HIV incidence was due to participants' low HIV risk or PrEP effectiveness was unclear. Recently, a study from Africa 11 compared HIV incidence among D-PrEP and ED-PrEP users with that of historical controls. To our knowledge, no study has included a parallel group of PrEP nonusers.…”
Section: Introductionmentioning
confidence: 99%
“…3 ED-PrEP was first incorporated into European clinical guidelines in 2015, then endorsed by the World Health Organization in 2019, and incorporated into Australian PrEP prescribing guidelines in the same year. [6][7][8] Although ED-PrEP is a well-established method of taking PrEP in certain regions in Europe 4,5,9 and recently found to be a common method in West Africa, 10 this regimen is not as known as daily PrEP internationally.…”
Section: Introductionmentioning
confidence: 99%
“…Since the costs of these interventions are not all derived from the same study, the methodology of determining the unit costs of the different interventions in different countries may not be comparable. Oral PrEP costs may go down as implementation efficiencies are identified, and its cost-effectiveness will also increase if, as was demonstrated in the SEARCH and other studies, 31 , 47 , 48 , 49 users correctly identify periods when they are at higher risk and use the intervention during these periods. 50 Despite these limitations, the overall trends identified in this study of three sub-Saharan African countries with different epidemic characteristics should be applicable to other sub-Saharan African countries with generalized HIV epidemics.…”
Section: Discussionmentioning
confidence: 96%